Within the scope of our investigation, a substantial upregulation of PHF12 was discerned in non-small cell lung cancer (NSCLC) tumor specimens, displaying a noteworthy correlation with a less favorable clinical prognosis. This evidence concerns the gene PHF12 and non-small cell lung carcinoma.